Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apraglutide in adult subjects with short bowel syndrome and intestinal failure
jRCT2021210005Completed
- Sponsor
- VectivBio
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Randomised, double-blind trial of apraglutide in short bowel syndrome (SBS) and intestinal failure (IF) (3 arms), sponsored by VectivBio. Primary endpoint: Relative change from baseline in actual weekly parenteral support volume at Week 24. Started Aug 2021; status: completed.
02
Drugs
apraglutide
03
Conditions
short bowel syndrome (SBS)intestinal failure (IF)
Beyond the preview
Go deeper on jRCT2021210005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2021210005.